1. Home
  2. MRSN vs KLXE Comparison

MRSN vs KLXE Comparison

Compare MRSN & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • KLXE
  • Stock Information
  • Founded
  • MRSN 2001
  • KLXE 2018
  • Country
  • MRSN United States
  • KLXE United States
  • Employees
  • MRSN N/A
  • KLXE N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • MRSN Health Care
  • KLXE Energy
  • Exchange
  • MRSN Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • MRSN 37.0M
  • KLXE 35.8M
  • IPO Year
  • MRSN 2017
  • KLXE N/A
  • Fundamental
  • Price
  • MRSN $7.24
  • KLXE $1.79
  • Analyst Decision
  • MRSN Strong Buy
  • KLXE
  • Analyst Count
  • MRSN 4
  • KLXE 0
  • Target Price
  • MRSN $63.67
  • KLXE N/A
  • AVG Volume (30 Days)
  • MRSN 138.9K
  • KLXE 117.1K
  • Earning Date
  • MRSN 08-13-2025
  • KLXE 08-06-2025
  • Dividend Yield
  • MRSN N/A
  • KLXE N/A
  • EPS Growth
  • MRSN N/A
  • KLXE N/A
  • EPS
  • MRSN N/A
  • KLXE N/A
  • Revenue
  • MRSN $34,769,000.00
  • KLXE $667,400,000.00
  • Revenue This Year
  • MRSN N/A
  • KLXE N/A
  • Revenue Next Year
  • MRSN $1.03
  • KLXE $3.97
  • P/E Ratio
  • MRSN N/A
  • KLXE N/A
  • Revenue Growth
  • MRSN 16.14
  • KLXE N/A
  • 52 Week Low
  • MRSN $5.21
  • KLXE $1.46
  • 52 Week High
  • MRSN $70.75
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 48.99
  • KLXE 47.87
  • Support Level
  • MRSN $5.21
  • KLXE $1.75
  • Resistance Level
  • MRSN $7.68
  • KLXE $1.99
  • Average True Range (ATR)
  • MRSN 0.54
  • KLXE 0.15
  • MACD
  • MRSN 0.12
  • KLXE 0.02
  • Stochastic Oscillator
  • MRSN 81.04
  • KLXE 57.14

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: